PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31939088-10 2020 Mice treated with GW0742 showed significantly less severe behavioral deficits compared to the control group, accompanied by increased expression of PPAR-beta/delta and Bcl-2, and increased expression of IL-1beta, TNF-alpha, and Bax decreased simultaneously in the GW0742-treated group. GW0742 18-24 tumor necrosis factor Mus musculus 213-222 21765606-3 2011 Mice treated with copper and peroxisome proliferator-activated receptor beta/delta agonist GW0742 had significantly less body weight loss, less serum alanine aminotransferase increase, less tumor necrosis factor alpha, macrophage inflammatory protein-2 and 8-hydroxy-2"-deoxyguanosine upregulation than copper treated mice. GW0742 91-97 tumor necrosis factor Mus musculus 190-217 20709805-7 2010 Furthermore, in lipopolysaccharide-stimulated J774.A1 macrophages, GW0742 reduced TNFalpha production by inhibiting NF-kappaB activation. GW0742 67-73 tumor necrosis factor Mus musculus 82-90 20709805-8 2010 RNA silencing of PPARdelta abrogated the inhibitory effects of GW0742 on TNFalpha production. GW0742 63-69 tumor necrosis factor Mus musculus 73-81 18622026-5 2008 GW0742 treatment resulted in reduced serum ALT concentration and lower expression of CCl(4)-induced TNF-alpha, S100A6, monocyte chemoattractant protein-1 (MCP1), and TWEAKr in wild-type mice, and these effects were not observed in PPARbeta/delta-null mice. GW0742 0-6 tumor necrosis factor Mus musculus 100-109 18622687-6 2008 Protein and mRNA levels of the pro-inflammatory cytokines IL-6, IL-1beta and TNFalpha in BALF were found to be significantly decreased in GW0742-treated animals (30 mg/kg). GW0742 138-144 tumor necrosis factor Mus musculus 77-85 33790957-6 2021 The selective PPARbeta/delta agonist GW0742 significantly decreased inflammation-related mRNA expression in hDPCs (IL6, IL1beta, TNFalpha, MMP1, and MMP2) and RAW264.7 cells (Il6 and Tnfalpha). GW0742 37-43 tumor necrosis factor Mus musculus 129-137 33790957-6 2021 The selective PPARbeta/delta agonist GW0742 significantly decreased inflammation-related mRNA expression in hDPCs (IL6, IL1beta, TNFalpha, MMP1, and MMP2) and RAW264.7 cells (Il6 and Tnfalpha). GW0742 37-43 tumor necrosis factor Mus musculus 183-191